Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04903366 · ClinicalTrials.gov registry record
Absorption and Safety of Topical Timolol to Treat Chronic Wounds
A clinical trial, sponsored by VA Northern California Health Care System.
- Completed
- Registry status
- 40
- Enrollment target
NCT04903366 is a clinical trial that has completed, run by VA Northern California Health Care System. The registered enrollment target is 40 participants.
The verdict
NCT04903366 has completed, sponsored by VA Northern California Health Care System.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Topical timolol has been used primarily as eye drops to treat glaucoma for many years. Recent clinical experience has broadened its off-label use for a number of skin conditions, including slow-healing wounds. While there have been extensive safety studies performed on timolol administration to treat the eye, to date, no studies have documented absorption of timolol after applied on chronic wounds. Thus, the purpose of this study is to determine the blood levels of timolol in patients after topical administration to a chronic wound, and compare these levels with those of patients after administration of the same drug formulation on the eye for the indication of glaucoma.
Interventions
- DRUG Timolol Maleate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-11-21 |
| Est. Completion | 2020-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04903366
The ClinicalTrials.gov registry entry for NCT04903366 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Northern California Health Care System, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Timolol Maleate is the first listed.
NCT04903366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04903366 about?
NCT04903366 is a clinical study titled "Absorption and Safety of Topical Timolol to Treat Chronic Wounds". Topical timolol has been used primarily as eye drops to treat glaucoma for many years. Recent clinical experience has broadened its off-label use for a number of skin conditions, including slow-healing wounds. While there have been extensive safety studies performed on timolol administration to trea...
What is the current status of trial NCT04903366?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-11-21. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT04903366?
The interventions under investigation include: Timolol Maleate (DRUG).
Who is sponsoring clinical trial NCT04903366?
This trial is sponsored by VA Northern California Health Care System, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.